Original Research
Accepted on 31 Dec 2024
Targeting NANOS1 in Triple-Negative Breast Cancer: Synergistic Effects of Digoxin and PD-1 Inhibitors in Modulating the Tumor Immune Microenvironment
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2024
in Cancer Immunity and Immunotherapy
Original Research
Accepted on 31 Dec 2024
in Gastrointestinal Cancers: Colorectal Cancer
Perspective
Accepted on 31 Dec 2024
in Thoracic Oncology
Systematic Review
Accepted on 31 Dec 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 31 Dec 2024
in Genitourinary Oncology
Systematic Review
Accepted on 31 Dec 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Original Research
Accepted on 31 Dec 2024
in Neuro-Oncology and Neurosurgical Oncology
Original Research
Accepted on 31 Dec 2024
in Surgical Oncology
Original Research
Accepted on 31 Dec 2024
in Cancer Imaging and Image-directed Interventions
Original Research
Accepted on 31 Dec 2024
in Radiation Oncology
Systematic Review
Accepted on 31 Dec 2024
in Molecular and Cellular Oncology
Correction
Accepted on 31 Dec 2024
in Radiation Oncology
Review
Accepted on 31 Dec 2024
in Surgical Oncology
Review
Accepted on 31 Dec 2024
in Cancer Molecular Targets and Therapeutics
Systematic Review
Accepted on 31 Dec 2024
in Gastrointestinal Cancers: Hepato Pancreatic Biliary Cancers
Correction
Accepted on 31 Dec 2024
in Cancer Molecular Targets and Therapeutics